BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37751032)

  • 21. The Role of VASOGRADE as a Simple Grading Scale to Predict Delayed Cerebral Ischemia and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Oliveira Souza NV; Rouanet C; Solla DJF; de Lima CVB; de Souza CA; Rezende F; Alves MM; de Oliveira Manuel AL; Chaddad Neto F; Frudit M; Silva GS
    Neurocrit Care; 2023 Feb; 38(1):96-104. PubMed ID: 36002635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Jeon JS; Sheen SH; Hwang G; Kang SH; Heo DH; Cho YJ
    J Korean Neurosurg Soc; 2012 Aug; 52(2):75-9. PubMed ID: 23091662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
    Takeuchi S; Mori K; Arimoto H; Fujii K; Nagatani K; Tomura S; Otani N; Osada H; Wada K
    BMC Neurol; 2014 Sep; 14():176. PubMed ID: 25201463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary and standardized management of patients with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Abdulazim A; Küppers C; Hackenberg KAM; Neumaier-Probst E; Alzghloul MM; Krebs J; Thiel M; Lingsma H; Rinkel GJE; Groden C; Etminan N
    Acta Neurochir (Wien); 2022 Nov; 164(11):2917-2926. PubMed ID: 36006507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.
    Thompson JC; Chalet FX; Manalastas EJ; Hawkins N; Sarri G; Talbot DA
    Neurol Ther; 2022 Jun; 11(2):597-620. PubMed ID: 35441974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
    J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
    Wong GK; Poon WS; Chan MT; Boet R; Gin T; Ng SC; Zee BC;
    Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status.
    Wong GK; Chan MT; Gin T; Poon WS
    Acta Neurochir Suppl; 2011; 110(Pt 2):169-73. PubMed ID: 21125466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.
    Golan E; Vasquez DN; Ferguson ND; Adhikari NK; Scales DC
    J Crit Care; 2013 Apr; 28(2):173-81. PubMed ID: 23192249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: an updated meta-analysis.
    Lee KS; Lee C; Dhillon PS; Kirollos R; Nga VDW; Yeo TT; Henkes H; Arthur AS; Yeo LLL; Bhogal P
    Neurosurg Rev; 2023 Sep; 46(1):221. PubMed ID: 37665377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of magnesium sulfate on cerebral vasospasm in the treatment of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Zheng H; Guo X; Huang X; Xiong Y; Gao W; Ke C; Chen C; Pan Z; Ye L; Wang L; Hu W; Zheng F
    Front Neurol; 2023; 14():1249369. PubMed ID: 38020616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Rowland MJ; Garry P; Westbrook J; Corkill R; Antoniades CA; Pattinson KTS
    J Neurosurg; 2017 Oct; 127(4):754-760. PubMed ID: 27935361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra-early angiographic vasospasm associated with delayed cerebral ischemia and infarction following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Roh D; Lahiri S; Meyers E; Witsch J; Frey HP; Dangayach N; Falo C; Mayer SA; Agarwal S; Park S; Meyers PM; Connolly ES; Claassen J; Schmidt JM
    J Neurosurg; 2017 May; 126(5):1545-1551. PubMed ID: 27231975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?
    Croci DM; Dalolio M; Aghlmandi S; Taub E; Rychen J; Chiappini A; Zumofen D; Guzman R; Mariani L; Roethlisberger M
    Neurol Res; 2021 Jan; 43(1):40-53. PubMed ID: 33106124
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of temporary clipping during aneurysm surgery on the incidence of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
    J Neurosurg; 2018 Jul; 129(1):84-90. PubMed ID: 28946178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Reddy D; Fallah A; Petropoulos JA; Farrokhyar F; Macdonald RL; Jichici D
    Neurocrit Care; 2014 Oct; 21(2):356-64. PubMed ID: 24619389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive therapies of delayed cerebral ischemia after subarachnoid hemorrhage: a propensity-matched comparison of different center-driven strategies.
    Labeyrie MA; Simonato D; Gargalas S; Morisson L; Cortese J; Ganau M; Fuschi M; Patel J; Froelich S; Gaugain S; Chousterman B; Houdart E
    Acta Neurochir (Wien); 2021 Oct; 163(10):2723-2731. PubMed ID: 34302553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarker Associations in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.
    Spantler D; Molnar T; Simon D; Berki T; Buki A; Schwarcz A; Csecsei P
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.